Related Experiment Video
Updated: Aug 11, 2026
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Desensitization to hydroxychloroquine--experience of 4 patients
Michal Mates1, Shoshana Zevin, Gabriel S Breuer
1Department of Internal Medicine and Rheumatology Clinic, Department of Pediatrics and Pediatric Rheumatology Clinic, Shaare Zedek Medical Center, Jerusalem, Israel. rheum@szmc.org.il
Abstract:
Hydroxychloroquine (HCQ) is an antimalarial agent with immunomodulatory effects. It is widely used in rheumatologic diseases, and has a very high efficacy/toxicity ratio. It is particularly important in the treatment of systemic lupus erythematosus (SLE) since it reduces new organ involvement and disease flares, and relieves skin and joint symptoms. Some patients develop hypersensitivity rash in response to HCQ. In such patients the drug is withdrawn and replaced by another medication. All the alternative medications for rheumatological patients are significantly more toxic than HCQ. We describe our initial experience of HCQ slow oral desensitization. All 4 patients who were recruited completed the procedure successfully without significant difficulty. Our results suggest that HCQ slow oral desensitization is safe, effective, and easy to perform.
